Industry · SIC 2835
In Vitro & In Vivo Diagnostic Substances
126 tracked issuers filing with the SEC under this industry classification.
Issuers
126
Recent filings
40
SIC code
2835
Industry overview
In Vitro & In Vivo Diagnostic Substances
Covering makers of reagents, assay kits, biomarkers, and companion diagnostics for lab benches and animal models, SIC 2835 serves hospitals, clinical reference labs, biotech and pharma R&D teams, and contract research organizations that rely on precise in vitro and in vivo diagnostic substances to validate therapies and guide patient care. Firms balance innovation with strict oversight from FDA/EMA pathways, CLIA compliance, data integrity rules, reimbursement scrutiny, and supply-chain or contamination risks that can erode assay reliability and margins. The 2024-2025 landscape is defined by multiplex and point-of-care platforms, AI-augmented analysis, liquid biopsy targets, and personalized medicine partnerships that demand robust quality systems and transparent performance claims. Competitive differentiation hinges on sensitivity, speed, and integration with digital workflows while managing cost pressures and evolving EU IVDR timelines. Track how market leaders navigate these dynamics and view SEC filings on Earnings Feed to spot emerging moves in this tightly regulated niche.
Source: Earnings Feed research · Nov 23, 2025
Latest filings
- 10-QBMRABIOMERICA INC4.2 MBSEC(opens sec.gov)
- 8-KBMRABIOMERICA INC198.2 KBSEC(opens sec.gov)
- 8-KLNTHLantheus Holdings, Inc.145.4 KBSEC(opens sec.gov)
- 8-KICCCIMMUCELL CORP /DE/178.8 KBSEC(opens sec.gov)
- 8-KMYGNMYRIAD GENETICS INC245.8 KBSEC(opens sec.gov)
- 6-KVRAXVirax Biolabs Group Ltd29.7 KBSEC(opens sec.gov)
- 10-QNEOGNEOGEN CORP9.7 MBSEC(opens sec.gov)
- SCHEDULE 13G/ACLDXCelldex Therapeutics, Inc.12.0 KBSEC(opens sec.gov)
- SCHEDULE 13G/AQDELQuidelOrtho Corp11.6 KBSEC(opens sec.gov)
- 8-KNEOGNEOGEN CORP217.5 KBSEC(opens sec.gov)
- 8-KNEOGNEOGEN CORP1.1 MBSEC(opens sec.gov)
- 144NTLASEC(opens sec.gov)
- 6-KTRIBTRINITY BIOTECH PLC16.9 KBSEC(opens sec.gov)
- 8-KLNTHLantheus Holdings, Inc.196.4 KBSEC(opens sec.gov)
- 8-KACHVACHIEVE LIFE SCIENCES, INC.209.5 KBSEC(opens sec.gov)
- 10-K/ABMRABIOMERICA INC942.6 KBSEC(opens sec.gov)
- 8-KVNRXVOLITIONRX LTD137.9 KBSEC(opens sec.gov)
- 8-KQDELQuidelOrtho Corp799.3 KBSEC(opens sec.gov)
- 8-KCLDXCelldex Therapeutics, Inc.245.7 KBSEC(opens sec.gov)
- 8-KLNTHLantheus Holdings, Inc.159.6 KBSEC(opens sec.gov)
- 8-KIMDXSEC(opens sec.gov)
- 8-KQCLSQ/C TECHNOLOGIES, INC.349.6 KBSEC(opens sec.gov)
- 8-KCDIOSEC(opens sec.gov)
- SCHEDULE 13D/AVNRXVOLITIONRX LTD10.7 KBSEC(opens sec.gov)
- 8-KMYGNMYRIAD GENETICS INC206.2 KBSEC(opens sec.gov)
- 8-KVNRXVOLITIONRX LTD137.7 KBSEC(opens sec.gov)
- 8-KVNRXVOLITIONRX LTD150.9 KBSEC(opens sec.gov)
- 4HOUGEN ELIZABETH L5.5 KBSEC(opens sec.gov)
- 8-KQCLSQ/C TECHNOLOGIES, INC.205.4 KBSEC(opens sec.gov)
- 6-KTRIBTRINITY BIOTECH PLC71.9 KBSEC(opens sec.gov)
- 4HOUGEN ELIZABETH L5.5 KBSEC(opens sec.gov)
- 6-KTRIBTRINITY BIOTECH PLC3.5 MBSEC(opens sec.gov)
- 4LNTHLantheus Holdings, Inc.10.1 KBSEC(opens sec.gov)
- 8-KNTLAIntellia Therapeutics, Inc.258.0 KBSEC(opens sec.gov)
- SCHEDULE 13DVNRXVOLITIONRX LTD26.4 KBSEC(opens sec.gov)
- 4LNTHLantheus Holdings, Inc.8.1 KBSEC(opens sec.gov)
- 6-KVRAXVirax Biolabs Group Ltd240.3 KBSEC(opens sec.gov)
- 8-KNTLAIntellia Therapeutics, Inc.236.2 KBSEC(opens sec.gov)
- 144IDXXSEC(opens sec.gov)
- SCHEDULE 13GMYGNMYRIAD GENETICS INC10.9 KBSEC(opens sec.gov)
Featured issuers
- ABLE LABORATORIES INCCIK 0000857171
- ACCUMED INTERNATIONAL INCCIK 0000888335
- ACHIEVE LIFE SCIENCES, INC.CIK 0000949858ACHV
- ALERE INC.CIK 0001145460
- ALERE SAN DIEGO, INC.CIK 0000834306
- ALLIANCE PHARMACEUTICAL CORP.CIK 0000736994
- Alpha Teknova, Inc.CIK 0001850902TKNO
- AMERSHAM PLCCIK 0001041799
- Anbio BiotechnologyCIK 0001982708NNNN
- ANSYS DIAGNOSTICS INCCIK 0001068965
- ANTHRA PHARMACEUTICALS INCCIK 0001054839
- APROGENEX INCCIK 0000907285
Classification
- SIC code
- 2835
- Total issuers
- 126
- Recent filings
- 40